K isn’t idle. They are moving forward with a K pill and drafting a proposal to the FDA for both a bridge study and and the next phase study once the bridge study establishes it's essentially the same drug in both MOA and safety.
Plan A is partnership or license, Plan B is PIPE (I’m in if it comes to that), Plan C is sell something, Plan D is hit the VCs.....